Robuta

https://pubmed.ncbi.nlm.nih.gov/37853676/
These data demonstrate OMDI efficacy and safety in latanoprost low/nonresponders with POAG or OHT, suggesting OMDI is a treatment option in the patient...
omidenepag isopropyllatanoprostlowprimaryopen